Plexcera Therapeutics (United States)

Treatment with pentosan polysulphate in patients with MPS I: results from an open label, randomized, monocentric phase II study

Julia B. Hennermann, Seyfullah Gökce, Alexander Sólyom et al. · Journal of Inherited Metabolic Disease · 2016 · 42 citations

Medicine, Pharmacology, Pharmacotherapy +3

Acid Ceramidase Deficiency is characterized by a unique plasma cytokine and ceramide profile that is altered by therapy

Shaalee Dworski, Ping Lu, Bruno Maranda et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2016 · 41 citations · Full text

Life Sciences, Biochemistry, Immunology +14

Loss of acid ceramidase in myeloid cells suppresses intestinal neutrophil recruitment

Mel Pilar Espaillat, Ashley J. Snider, Zhijuan Qiu et al. · The FASEB Journal · 2017 · 29 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Polyarticular Arthritis and Spinal Muscular Atrophy in Acid Ceramidase Deficiency

Hooi Ling Teoh, Alexander Sólyom, Edward H. Schuchman et al. · PEDIATRICS · 2016 · 19 citations · Full text

Life Sciences, Genetics, Neurology +17

Farber disease: Implications of anti-inflammatory treatment

John J. Mitchell, Alexander Sólyom, Balahan Makay et al. · Molecular Genetics and Metabolism · 2016 · 10 citations

Life Sciences, Immunology, Pharmacotherapy +8